InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Chakma Justin. Insider active across 1 company, notably ARS Pharmaceuticals, Inc.. Aggregated, 7 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €438k. Activity tracked since 25 November 2024. The latest transaction was disclosed on 12 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Chakma Justin is a declarant linked to ARS Pharmaceuticals, Inc., where he is Chief Business Officer. Across 6 total filings, the 6 sampled filings cover the period from 2022-11-10 to 2024-12-13, with 0 in purchases and 438385 in sales, and the modal transaction nature is Levée d'options.